|
US4514506A
(en)
|
1982-02-23 |
1985-04-30 |
The Government Of The United States As Represented By The Secretary Of The Department Of Health And Human Services |
Method for the identification and purification of human lung tumor-associated antigens (hLTAA) and clinical detection and determination of these antigens
|
|
EP0273085A1
(en)
|
1986-12-29 |
1988-07-06 |
IntraCel Corporation |
A method for internalizing nucleic acids into eukaryotic cells
|
|
FR2610631B1
(fr)
|
1987-02-09 |
1989-11-24 |
Pasteur Institut |
Molecules comportant au moins une sequence peptidique porteuse d'un ou plusieurs, epitope caracteristique d'une proteine produite par p. falciparum dans les hepatocytes, et leurs utilisations, notamment pour le diagnostic du paludisme ou dans des compositions de vaccins contre le paludisme
|
|
US5869608A
(en)
|
1989-03-17 |
1999-02-09 |
The United States Of America As Represented By The Department Of Health And Human Services |
Nucleotide and amino acid sequences of the four variable domains of the major outer membrane proteins of Chlamydia trachomatis
|
|
US5550318A
(en)
|
1990-04-17 |
1996-08-27 |
Dekalb Genetics Corporation |
Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof
|
|
US5484956A
(en)
|
1990-01-22 |
1996-01-16 |
Dekalb Genetics Corporation |
Fertile transgenic Zea mays plant comprising heterologous DNA encoding Bacillus thuringiensis endotoxin
|
|
US5384253A
(en)
|
1990-12-28 |
1995-01-24 |
Dekalb Genetics Corporation |
Genetic transformation of maize cells by electroporation of cells pretreated with pectin degrading enzymes
|
|
GB9105383D0
(en)
|
1991-03-14 |
1991-05-01 |
Immunology Ltd |
An immunotherapeutic for cervical cancer
|
|
CA2067031C
(en)
|
1991-04-26 |
2003-02-18 |
Shigekazu Nagata |
Dna coding for human cell surface antigen
|
|
US5780036A
(en)
|
1991-08-26 |
1998-07-14 |
The Scripps Research Institute |
Peptides for inducing cytotoxic T lymphocyte responses to hepattis B virus
|
|
US5610042A
(en)
|
1991-10-07 |
1997-03-11 |
Ciba-Geigy Corporation |
Methods for stable transformation of wheat
|
|
DE4228457A1
(de)
|
1992-08-27 |
1994-04-28 |
Beiersdorf Ag |
Herstellung von heterodimerem PDGF-AB mit Hilfe eines bicistronischen Vektorsystems in Säugerzellen
|
|
GB9222888D0
(en)
|
1992-10-30 |
1992-12-16 |
British Tech Group |
Tomography
|
|
US5869337A
(en)
|
1993-02-12 |
1999-02-09 |
President And Fellows Of Harvard College |
Regulated transcription of targeted genes and other biological events
|
|
US5834266A
(en)
|
1993-02-12 |
1998-11-10 |
President & Fellows Of Harvard College |
Regulated apoptosis
|
|
WO1994018317A1
(en)
|
1993-02-12 |
1994-08-18 |
The Board Of Trustees Of The Leland Stanford Junior University |
Regulated transcription of targeted genes and other biological events
|
|
US5830462A
(en)
|
1993-02-12 |
1998-11-03 |
President & Fellows Of Harvard College |
Regulated transcription of targeted genes and other biological events
|
|
US5426027A
(en)
|
1993-05-20 |
1995-06-20 |
The Government Of The United States Of America As Represented By The Secretary |
Nucleic acid probes and methods for detecting Candida DNA cells in blood
|
|
US5648226A
(en)
|
1993-07-22 |
1997-07-15 |
Ludwig Institute For Cancer Research |
Isolated peptides derived from tumor rejection antigens, and their use
|
|
JPH09502086A
(ja)
|
1993-08-06 |
1997-03-04 |
サイテル コーポレイション |
完全ｍａｇｅ１遺伝子のクローニング及び特性決定
|
|
US5550214A
(en)
|
1994-02-10 |
1996-08-27 |
Brigham And Women's Hospital |
Isolated antigenic oncogene peptide fragments and uses
|
|
US5709995A
(en)
|
1994-03-17 |
1998-01-20 |
The Scripps Research Institute |
Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses
|
|
FR2722208B1
(fr)
|
1994-07-05 |
1996-10-04 |
Inst Nat Sante Rech Med |
Nouveau site interne d'entree des ribosomes, vecteur le contenant et utilisation therapeutique
|
|
JPH11511643A
(ja)
|
1994-10-25 |
1999-10-12 |
ザ・ボード・オブ・トラスティーズ・オブ・ザ・リランド・スタンフォード・ジュニア・ユニバーシティ |
遺伝子工学処理された細胞の条件的形質転換
|
|
US5741899A
(en)
|
1995-02-02 |
1998-04-21 |
Cell Genesys, Inc. |
Chimeric receptors comprising janus kinase for regulating cellular pro liferation
|
|
US5840839A
(en)
|
1996-02-09 |
1998-11-24 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein
|
|
US5853719A
(en)
|
1996-04-30 |
1998-12-29 |
Duke University |
Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
|
|
US6010878A
(en)
|
1996-05-20 |
2000-01-04 |
Smithkline Beecham Corporation |
Interleukin-1 β converting enzyme like apoptotic protease-6
|
|
IL127912A0
(en)
|
1996-07-10 |
1999-11-30 |
Immunex Corp |
Method of activating dendritic cells
|
|
US5955596A
(en)
|
1996-07-26 |
1999-09-21 |
American Cyanamid Company |
NucA protein of Haemophilus influenzae and the gene encoding that protein
|
|
US6046158A
(en)
|
1996-12-20 |
2000-04-04 |
Board Of Regents The University Of Texas Systems |
Unique dendritic cell-associated C-type lectins, dectin-1 and dectin-2; compositions and uses thereof
|
|
US5965242A
(en)
|
1997-02-19 |
1999-10-12 |
Eastman Kodak Company |
Glow-in-the-dark medium and method of making
|
|
CN1224712C
(zh)
|
1997-06-04 |
2005-10-26 |
牛津生物医学（英国）有限公司 |
载体
|
|
US6969609B1
(en)
|
1998-12-09 |
2005-11-29 |
The United States Of America As Represented By The Department Of Health And Human Serivces |
Recombinant vector expressing multiple costimulatory molecules and uses thereof
|
|
US6403765B1
(en)
|
1998-06-16 |
2002-06-11 |
Thomas Jefferson University |
Truncated Apaf-1 and methods of use thereof
|
|
US6558951B1
(en)
|
1999-02-11 |
2003-05-06 |
3M Innovative Properties Company |
Maturation of dendritic cells with immune response modifying compounds
|
|
GB9930616D0
(en)
|
1999-12-24 |
2000-02-16 |
Mathilda & Terence Kennedy Ins |
Activation and inhibition of the immune system
|
|
US20030108527A1
(en)
|
1999-12-28 |
2003-06-12 |
Tsukasa Seya |
Maturation-promoting agent for immature dendrtic cells
|
|
US7435585B2
(en)
|
2000-01-03 |
2008-10-14 |
University Of Pennsylvania |
Auto-stimulating cells and methods for making and using the same
|
|
SE0001642D0
(sv)
|
2000-05-04 |
2000-05-04 |
Sahltech Ab |
Reagent for detection of biomolecules, and use thereof
|
|
US20030232055A1
(en)
|
2000-07-31 |
2003-12-18 |
Ruslan Medzhitov |
Innate immune system-directed vaccines
|
|
AU2001281252A1
(en)
|
2000-08-10 |
2002-02-18 |
Board Of Regents, The University Of Texas System |
The tumor suppressor car-1
|
|
WO2002036769A2
(en)
|
2000-10-31 |
2002-05-10 |
F. Hoffmann-La Roche Ag |
Nucleic acids encoding cd40/cd40l chimeric polypeptides, methods for their production and uses thereof
|
|
CA2427858A1
(en)
*
|
2000-11-03 |
2002-05-10 |
University Of Vermont And State Agricultural College |
Compositions for inhibiting grb7
|
|
WO2002054066A2
(en)
|
2000-12-14 |
2002-07-11 |
The Burnham Institute |
Non-apoptotic forms of cell death and methods of modulation
|
|
US20020160975A1
(en)
|
2001-02-08 |
2002-10-31 |
Thomas Jefferson University |
Conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO for mediating apoptosis
|
|
AU2002354560A1
(en)
|
2001-07-09 |
2003-01-29 |
Oklahoma Medical Research Foundation |
Targeted fusion proteins and methods for the characterization of cellular membrane domains
|
|
WO2003024480A2
(en)
|
2001-09-14 |
2003-03-27 |
Cytos Biotechnology Ag |
In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
|
|
US20050215472A1
(en)
|
2001-10-23 |
2005-09-29 |
Psma Development Company, Llc |
PSMA formulations and uses thereof
|
|
WO2003035003A2
(en)
|
2001-10-26 |
2003-05-01 |
Cleveland Clinic Foundation |
Fused cells, methods of forming same, and therapie utilizing same
|
|
EP2933334B1
(en)
|
2003-02-18 |
2019-09-18 |
Baylor College of Medicine |
Induced activation in dendritic cells
|
|
EP1589030A1
(en)
|
2004-04-14 |
2005-10-26 |
Friedrich-Alexander-Universität Erlangen-Nürnberg |
Bob-1 specific T cells and methods to use
|
|
US20080274140A1
(en)
|
2004-11-19 |
2008-11-06 |
David B Weiner |
Vaccines and Methods for Using the Same
|
|
CA2593648A1
(en)
|
2005-01-10 |
2006-07-13 |
Research Development Foundation |
Targeted chimeric molecules for cancer therapy
|
|
WO2006133398A2
(en)
|
2005-06-08 |
2006-12-14 |
Invitrogen Corporation |
In vitro activated donor t-cells to promote transplant engraftment
|
|
KR100705981B1
(ko)
|
2005-10-12 |
2007-04-10 |
주식회사 리제론 |
인간 성장호르몬을 포함하는 탈모방지 또는 발모촉진용조성물
|
|
GB0526210D0
(en)
|
2005-12-22 |
2006-02-01 |
Oxford Biomedica Ltd |
Vectors
|
|
GB0526211D0
(en)
|
2005-12-22 |
2006-02-01 |
Oxford Biomedica Ltd |
Viral vectors
|
|
US20080300202A1
(en)
|
2006-05-18 |
2008-12-04 |
The State of Oregon acting by and through the State Board of Higher Education on behalf of the |
Subtractive transgenics
|
|
US20100196336A1
(en)
|
2006-05-23 |
2010-08-05 |
Dongsu Park |
Modified dendritic cells having enhanced survival and immunogenicity and related compositions and methods
|
|
US20120328628A1
(en)
|
2006-07-07 |
2012-12-27 |
The Regents Of The University Of California |
Antibodies to conformationally trapped proteins
|
|
EP2465510B1
(en)
|
2006-10-19 |
2018-11-28 |
Baylor College Of Medicine |
Methods and compositions for generating an immune response by inducing CD40 and pattern recognition receptors and adaptors thereof
|
|
US9213999B2
(en)
|
2007-06-15 |
2015-12-15 |
Kyoto University |
Providing iPSCs to a customer
|
|
JP2008307007A
(ja)
|
2007-06-15 |
2008-12-25 |
Bayer Schering Pharma Ag |
出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
|
|
EP2006376A1
(en)
|
2007-06-21 |
2008-12-24 |
Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH |
Fusion protein comprising a caspase domain and a nuclear hormone receptor binding domain and methods and uses thereof
|
|
CA2704583A1
(en)
|
2007-11-07 |
2009-05-14 |
Celldex Therapeutics Inc. |
Antibodies that bind human dendritic and epithelial cell 205 receptor(dec-205)
|
|
EP2262530A4
(en)
|
2008-03-03 |
2012-12-05 |
Dyax Corp |
Metalloproteinase-12 TIE PROTEINS
|
|
JP5615271B2
(ja)
|
2008-06-18 |
2014-10-29 |
オックスフォード バイオメディカ（ユーケー）リミテッド |
ウイルス精製法
|
|
EP3238739B1
(en)
|
2008-09-22 |
2020-10-21 |
Baylor College of Medicine |
Methods and compositions for generating an immune response by inducing cd40 and pattern recognition receptor adapters
|
|
CN102272153B
(zh)
*
|
2008-11-24 |
2015-04-15 |
德国慕尼黑亥姆霍兹研究中心健康和环境有限公司 |
高亲和力t细胞受体及其应用
|
|
WO2011035018A2
(en)
|
2009-09-18 |
2011-03-24 |
Fate Therapeutics, Inc. |
Suicide ready cells
|
|
EP2558109A4
(en)
|
2010-04-16 |
2014-09-24 |
Bellicum Pharmaceuticals Inc |
METHOD FOR TREATING HARD TUMORS
|
|
US9089520B2
(en)
|
2010-05-21 |
2015-07-28 |
Baylor College Of Medicine |
Methods for inducing selective apoptosis
|
|
US9434935B2
(en)
|
2013-03-10 |
2016-09-06 |
Bellicum Pharmaceuticals, Inc. |
Modified caspase polypeptides and uses thereof
|
|
SG11201506974XA
(en)
|
2013-03-14 |
2015-10-29 |
Bellicum Pharmaceuticals Inc |
Methods for controlling t cell proliferation
|
|
CA2912172A1
(en)
|
2013-06-05 |
2014-12-11 |
Bellicum Pharmaceuticals, Inc. |
Methods for inducing partial apoptosis using caspase polypeptides
|
|
CN106132423B
(zh)
|
2014-02-14 |
2020-07-31 |
贝里坤制药股份有限公司 |
用诱导型嵌合多肽活化t细胞的方法
|
|
CA2940460A1
(en)
|
2014-03-07 |
2015-09-11 |
Bellicum Pharmaceuticals, Inc. |
Caspase polypeptides having modified activity and uses thereof
|
|
CA2966300C
(en)
|
2014-11-03 |
2023-07-11 |
Mirjam H.M. Heemskerk |
T cell receptors directed against bob1 and uses thereof
|